ESSILORLUXOTTICA 1/2/O.N.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, … Read more
ESSILORLUXOTTICA 1/2/O.N. (ESLC) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ESSILORLUXOTTICA 1/2/O.N. (ESLC) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ESSILORLUXOTTICA 1/2/O.N. - Net Assets Trend (None–None)
This chart illustrates how ESSILORLUXOTTICA 1/2/O.N.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ESSILORLUXOTTICA 1/2/O.N. (None–None)
The table below shows the annual net assets of ESSILORLUXOTTICA 1/2/O.N. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ESSILORLUXOTTICA 1/2/O.N.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ESSILORLUXOTTICA 1/2/O.N. Competitors by Market Cap
The table below lists competitors of ESSILORLUXOTTICA 1/2/O.N. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Japan Tobacco Inc
PINK:JAPAF
|
$31.32 Billion |
|
United Overseas Bank Limited
PINK:UOVEF
|
$31.36 Billion |
|
Agilent Technologies Inc
NYSE:A
|
$31.54 Billion |
|
Carnival Plc ADS
NYSE:CUK
|
$31.61 Billion |
|
Kotak Mahindra Bank Limited
NSE:KOTAKBANK
|
$31.22 Billion |
|
National Bank of Canada
PINK:NTIOF
|
$31.06 Billion |
|
Daikin IndustriesLtd
PINK:DKILF
|
$30.85 Billion |
|
BLOCK INC. CDI/1/1
F:F8O
|
$30.83 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ESSILORLUXOTTICA 1/2/O.N.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ESSILORLUXOTTICA 1/2/O.N.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ESSILORLUXOTTICA 1/2/O.N. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ESSILORLUXOTTICA 1/2/O.N.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ESSILORLUXOTTICA 1/2/O.N. (ESLC) | €- | N/A | N/A | $31.26 Billion |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $479.33 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.76 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $216.48 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $783.58 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.27 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.26 Billion |